Say Pharmanal-Q Solutions Private Limited
About Say Pharmanal-Q Solutions Private Limited
Data last updated:
Say Pharmanal-Q Solutions Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 19 February 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74900MH2014PTC253395. Its GSTIN is 27AAUCS4404P1ZL (Maharashtra).
The company has an authorised share capital of ₹11 Lakh and a paid-up capital of ₹11 Lakh. It is led by directors Ashok Arjun Mhaske and Sapana Sachin Bagal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 3rd Floor Plot No. C56/1 Ttc Industrial Area MIDC Turbhe Navi Mumbai, Thane, Maharashtra, India – 400710.
As per the financials filed for FY 2025, the company reported a revenue of ₹10.36 Lakh, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹1.41 Lakh (net margin 13.6%) and EBITDA of ₹1.93 Lakh (EBITDA margin 18.6%). Revenue has declined at a compounded annual rate (CAGR) of 20% over three years and 3% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Say Pharmanal-Q Solutions Private Limited's registered office is in Thane, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address3rd Floor Plot No. C56/1 Ttc Industrial Area MIDC Turbhe Navi Mumbai, Thane, Maharashtra, India – 400710
- IndustryBusiness Services, Miscellaneous Business Activities
To see the full contact details of Say Pharmanal-Q Solutions Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Say Pharmanal-Q Solutions is professional, scientific and technical activities. In detail, this covers architectural and engineering activities; technical testing and analysis.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, scientific and technical activities | 71 | Architectural and engineering activities; technical testing and analysis |
To see the full business activity and turnover split of Say Pharmanal-Q Solutions Private Limited, buy the company report.
Financials of Say Pharmanal-Q Solutions Private Limited
FY 2025 filings availableSay Pharmanal-Q Solutions Private Limited reported revenue of ₹10.36 Lakh (up 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 8% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 3%. EBITDA rose 31% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.93 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.41 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 18.6% | ||||
| Net Profit Margin | 13.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Say Pharmanal-Q Solutions Private Limited, buy the company report.
Board of directors of Say Pharmanal-Q Solutions Private Limited
Say Pharmanal-Q Solutions has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sapana Sachin Bagal | Additional Director | 04 Oct 2017 | 9 Years 0 Months | Current |
| Ashok Arjun Mhaske | Director | 05 Jul 2025 | 1 Years 3 Months | Current |
Peer comparison
Say Pharmanal-Q Solutions Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (architectural and engineering activities; technical testing and analysis), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| ZS Engineering Works Private Limited | ₹10.59 Lakh (FY 2025) | -21.0% | Navi Mumbai, Maharashtra, India | |||
| S.N.M. Consultants Pvt. Ltd. | ₹10.57 Lakh (FY 2025) | 11.0% | Kolkata, West Bengal, India | |||
| Intarch Design Associates Private Limited | ₹10.53 Lakh (FY 2025) | -31.0% | New Delhi, Delhi, India | |||
| Incept Projects and Services Private Limited | ₹10.48 Lakh (FY 2024) | -19.0% | New Delhi, Delhi, India | |||
| Ssym Designs (OPC) Private Limited | ₹10.47 Lakh (FY 2024) | Jaipur, Rajasthan, India | ||||
| Say Pharmanal-Q Solutions Private Limitedthis company | ₹10.36 Lakh (FY 2025) | ₹1.41 Lakh | 13.6% | 8.0% | Thane, Maharashtra, India | |
| SSVL Infra Design and Safety Solutions Private Limited | ₹10.3 Lakh (FY 2024) | Patna, Bihar, India | ||||
| Supa Build Private Limited | ₹10.25 Lakh (FY 2025) | Bangalore, Karnataka, India | ||||
| Sterling Lomax Project Services India Private Limited | ₹10.15 Lakh (FY 2025) | -37.0% | Mumbai, Maharashtra, India | |||
| Jwala Inventive Private Limited | ₹10.06 Lakh (FY 2024) | -37.0% | Pune, Maharashtra, India | |||
| Toshah Technocrats Private Limited | ₹10.02 Lakh (FY 2025) | -54.0% | Noida, Uttar Pradesh, India |
To see the full peer comparison of Say Pharmanal-Q Solutions Private Limited, buy the company report.
Auditor
Say Pharmanal-Q Solutions Private Limited is audited by AVPR & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AVPR & ASSOCIATES | FY 2017 | 002679C |
Shareholding
The shareholding of Say Pharmanal-Q Solutions Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Say Pharmanal-Q Solutions Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Say Pharmanal-Q Solutions Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Say Pharmanal-Q Solutions Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Say Pharmanal-Q Solutions has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAUCS4404P1ZL | Maharashtra | Active | 02 Jan 2018 |
To see the full GST registrations and return filing status of Say Pharmanal-Q Solutions Private Limited, buy the company report.
Recent activity
Say Pharmanal-Q Solutions Private Limited has 5 board changes on record since 2014: 3 appointments and 2 cessations. The latest: Ashok Arjun Mhaske was appointed as Director on 05 Jul 2025.
Frequently asked questions
Say Pharmanal-Q Solutions is an active private limited company based in Thane, Maharashtra, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 19 February 2014 (12+ years old) and is registered under CIN U74900MH2014PTC253395.
Say Pharmanal-Q Solutions has 2 current directors:
- Sapana Sachin Bagal - Additional Director
- Ashok Arjun Mhaske - Director
The latest financial statements of Say Pharmanal-Q Solutions on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Say Pharmanal-Q Solutions is 27AAUCS4404P1ZL, registered in Maharashtra.
The CIN (Corporate Identification Number) of Say Pharmanal-Q Solutions is U74900MH2014PTC253395. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Say Pharmanal-Q Solutions was incorporated on 19 February 2014, making it 12+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Say Pharmanal-Q Solutions by revenue are ZS Engineering Works Private Limited, S.N.M. Consultants Pvt. Ltd, Intarch Design Associates Private Limited, Incept Projects and Services Private Limited, Ssym Designs (OPC) Private Limited and 5 more, all in the same principal business activity (architectural and engineering activities; technical testing and analysis).
Ashok Arjun Mhaske was appointed as Director on 05 Jul 2025. Parshuram Bajirao Gholap ceased to be Director on 01 Aug 2022. Ashok Arjun Mhaske ceased to be Whole-Time Director on 05 Oct 2017. Say Pharmanal-Q Solutions has 5 board changes on record in total.
The registered office of Say Pharmanal-Q Solutions is at 3rd Floor Plot No. C561 Ttc Industrial Area MIDC Turbhe Navi Mumbai, Thane, Maharashtra, India – 400710.
Say Pharmanal-Q Solutions operates in the business services industry, in the miscellaneous business activities segment.
The compliance status of Say Pharmanal-Q Solutions is compliant as of 09 July 2026. The company is actively filing with the Registrar of Companies.